Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates

无症状颈动脉狭窄：认知功能和斑块相关

• 批准号: 8392973
• 负责人: Brajesh K Lal
• 金额: --
• 依托单位: BALTIMORE VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8392973
• 关键词: Address; Affect; Age; Architecture; Behavior Control; Biological; Blood; Blood Vessels; Blood flow; Brain; Brain Injuries; Caliber; Cardiovascular system; Carotid Artery Plaques; Carotid Stenosis; Cerebrum; Characteristics; Chemicals; Clinical; Cognitive; Cognitive deficits; Conscious; Country; Elderly; Focal Neurologic Deficits; Foundations; Future; Goals; Health; Hospitals; Imaging Techniques; Impaired cognition; Impairment; Independent Living; Individual; Investigation; Label; Learning; Measurement; Measures; Mediating; Mediator of activation protein; Mental Processes; Morbidity - disease rate; Morphology; Operative Surgical Procedures; Outcome; Outcome Measure; Patient Selection; Patients; Personal Satisfaction; Persons; Prevention; Problem Solving; Procedures; Process; Production; Quality of life; Recruitment Activity; Rehabilitation therapy; Reporting; Resources; Risk; Role; Serum; Stenosis; Stroke; Stroke prevention; Structure; Support System; Techniques; Testing; Thinking; Three-Dimensional Imaging; Transient Ischemic Attack; Ultrasonography; Veterans; cerebral hypoperfusion; clinically significant; cognitive change; cognitive function; cognitive rehabilitation; follow-up; health related quality of life; hemodynamics; improved; inflammatory marker; novel; particle; prevent; programs; public health relevance; randomized trial

DESCRIPTION (provided by applicant): Carotid artery stenosis is a well-known cause of atheroembolic stroke. Stroke prevention in these patients has been the focus of intense investigation. Cognitive impairment is a more insidious but poorly understood outcome in patients with "asymptomatic" carotid stenosis who have not suffered a stroke. Cognitive function describes how a person produces and controls mental processes such as thinking, learning, and problem solving. It is an important outcome measure that affects patient well-being and their ability to live independent productive lies. It is well-known that cognitive impairment coexists in patients with stroke from carotid stenosis. However, isolated cognitive deficits in patients with asymptomatic carotid stenosis have not been looked for, and have therefore not been reported in any detail. Asymptomatic carotid stenosis affects 2-12% of people. With 23.4 million veterans in the country, at least 1 million (4.3%) have asymptomatic carotid stenosis and are at risk for cognitive impairment. A subset analysis of the Cardiovascular Health Study found cognitive decline in 34% of 32 patients with asymptomatic carotid stenosis. In this proposal, we will define the extent of initial and progressive cognitive impairment in veterans with carotid stenosis who are currently labeled as "asymptomatic" in the absence of a focal neurologic deficit (stroke, transient ischemic attack). Programs to prevent, postpone, or mitigate cognitive impairment in patients with carotid stenosis will depend on the identification of mediators for cognitive impairment. Microembolic brain injury and cerebral hypoperfusion have been associated with cognitive impairment in elderly individuals. Therefore plaque architecture, plaque composition, microembolic counts, serum inflammatory markers, and cerebral hypoperfusion are likely mediators of impaired cognition in patients with asymptomatic carotid stenosis. As part of this proposal, we will identify the biological mechanisms by which carotid stenosis could result in cognitive impairment. The goal of this proposal is to perform a systematic, adequately powered study to measure the magnitude of cognitive impairment in asymptomatic carotid stenosis, its impact on quality of life, and its potential pathophysiological mechanisms. Information from this study will define an unsuspected morbidity of carotid stenosis and identify subsets of patients at risk for cognitive impairment. It will form the foundation for future studies on prevention, pre-emptive treatment, or rehabilitation of patients with carotid stenosis. It will also improve the selection of patients with carotid stenosis to decrease unnecessary revascularization procedures. Specific Aim 1 will assess if patients with asymptomatic carotid stenosis differ in cognitive function compared to age-matched controls without carotid stenosis but with similar vascular risk profiles. We hypothesize that in patients with asymptomatic carotid stenosis 50% who survive stroke free for 2 years; the change in overall and domain-specific cognitive function will be significantly different compared to those without stenosis. The study will recruit 284 subjects and will detect a clinically significant difference in cognitive score with 90% power. We will use a novel battery of cognitive tests specifically developed to address the unique issues relating to carotid stenosis. Specific Aim 2 will define plaque-morphometric, biologic, and hemodynamic characteristics that correlate with cognitive impairment in patients with asymptomatic carotid stenosis. We hypothesize that carotid plaque architecture, plaque composition, microembolic counts, serum pro-inflammatory markers, and cerebral hypoperfusion could each mediate cognitive decline over a 2-year follow-up period. We will implement a novel clinical 3D B-mode ultrasound imaging technique developed to obtain reliable serial plaque measurements. Specific Aim 3 will measure the impact of cognitive impairment on quality of life. We hypothesize that at 2 years, regardless of plaque features, cognitive impairment will correlate with a reduction in health-related quality of life measures.

描述（由申请人提供）：